B.G. Negev Technologies and Applications Ltd.; at Ben-Gurion University
发明人:
申请号:
EP16832417.6
公开号:
EP3331511A4
申请日:
2016.07.27
申请国别(地区):
EP
年份:
2019
代理人:
摘要:
Provided are compositions which include N-methyl-d-aspartate receptor (NMDA-R) antagonists. Moreover, provided are methods for reducing the permeability of the blood-brain-barrier, in a patient, by administering to the patient, a composition which includes N-methyl-d-aspartate receptor (NMDA-R) antagonists.